hr breast cancer: prognostic subgroups in monarch trials
Published 6 years ago • 81 plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
6:07
hr breast cancer: updated results from monarch trials
-
3:06
hr breast cancer: pooled analysis from monarch 2 and 3
-
2:26
dr. goetz on the use of ctdna in the monarch-3 trial in hr /her2- breast cancer
-
2:02
dr. dickler on monarch 1 results in hr /her2- breast cancer
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
3:02
trial investigates multiparametric prognostic score in early hr /her2- breast cancer
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
8:39
final overall survival analysis of monarch 1
-
0:53
prognostic trials for 21-gene oncotypedx in hr /her2- breast cancer with micrometastases
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
1:43
dr gandhi on considerations for continuing cdk4/6 inhibitors after progression in hr breast cancer
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data